Loading
Getein Biotech, Inc: what insiders have been doing
This page follows insider dealings at Getein Biotech, Inc as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of Getein Biotech, Inc in twelve months, the latest record being from 15 August 2025.
Looking back to 2023, when coverage begins, insiders filed no purchases and 3 sales.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€6M
3 ops. · all time
Who traded when
BuySale南京爱基商务信息咨询有限公司1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,805 of 24,148 companies
62.4
score / 100
Value51
Quality73
FCF yld4.8%
Earn yld4.3%
EV/EBITDA17.1x
ROE10%
Gross mgn70%
Net mgn21%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥10.01
Analyst consensus
Income statement
RevenueCN¥1.1B
Gross profitCN¥734M70% margin
EBITDACN¥325.1M31% margin
Net incomeCN¥220.7M27.1% margin
Valuation
PER (trailing)17.0x
P/Book1.7x
Beta-0.04
Balance sheet & cash
Market capCN¥5.1B
Total debtCN¥482M
Free Cash FlowCN¥242M
Debt / Equity11%
Profitability & ownership
ROE10.0%
ROA4.1%
% insiders46.1%
% institutions1.5%
Last declaration on 15 August 2025
Declarations3 total
666,600 shares19.6% of flowA股XSHGSSE:173000009352563000
1,516,500 sharesA股XSHGSSE:173000006622090200
1,516,500 shares80.4% of flowA股XSHGSSE:173000006622090180
3 of 3 declarations
About Getein Biotech, Inc
基蛋生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of medical diagnostics.
